Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Cellebrite DI Ltd. covers the month of August 2024, with a report date of August 15, 2024. The filing addresses a specific corporate event triggered by the company's stock price performance rather than routine financial reporting.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a stock price milestone and the resulting equity adjustments.
Material Changes
On August 14, 2024, the dollar volume-weighted average price of Cellebrite's ordinary shares reached or exceeded $12.50 per share for the twentieth trading day within a thirty-day period. This "Triggering Event" activated provisions in the Business Combination Agreement dated April 8, 2021, resulting in the following material changes:
- Issuance of Price Adjustment Shares: The company is required to issue 5,000,000 ordinary shares to existing shareholders on a pro-rata basis.
- Vesting of Shares: 3,000,000 ordinary shares held by TWC Tech Holdings II, LLC vested and had restrictions removed. These shares were part of a tranche of 7,500,000 shares subject to vesting upon specific triggering events.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, or new risk factors. The primary contingency noted is the issuance of shares subject to applicable withholding taxes.
Key Facts for Investor Verification
- Verify the exact number of shares issued to shareholders following the August 14, 2024 Triggering Event.
- Confirm the impact of the 5,000,000 new shares and the 3,000,000 vested shares on total outstanding share count and potential dilution.
- Review the specific terms of the remaining tranches of the 7,500,000 shares held by TWC Tech Holdings II, LLC to understand future vesting conditions.